Brief: Transcode Therapeutics Expands Executive Team With Appointment Of Dr. Michel Janicot As Senior Development Officer
17/11/2025 13:05
Transcode Therapeutics Inc RNAZ.O: TRANSCODE THERAPEUTICS EXPANDS EXECUTIVE TEAM WITH APPOINTMENT OF DR. MICHEL JANICOT AS SENIOR DEVELOPMENT OFFICER Source text: ID:nPn2HBvlTa Further company coverage: RNAZ.O
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors